Literature DB >> 24198303

Recurrent subthreshold depression in type 2 diabetes: an important risk factor for poor health outcomes.

Norbert Schmitz1, Geneviève Gariépy, Kimberley J Smith, Matthew Clyde, Ashok Malla, Richard Boyer, Irene Strychar, Alain Lesage, Jianli Wang.   

Abstract

OBJECTIVE To evaluate the association between recurrent subthreshold depressive episodes and functioning in a prospective community sample of people with type 2 diabetes. RESEARCH DESIGN AND METHODS A prospective community study in Quebec, Canada, was carried out between 2008 and 2013 (n = 1,064). Five yearly follow-up assessments (telephone interviews) were conducted. Baseline and the first three follow-up assessments were used to identify recurrent subthreshold depressive episodes (Patient Health Questionnaire [PHQ]-9). Functioning (World Health Organization Disability Assessment Schedule II [WHODAS-II]) and health-related quality of life (Centers for Disease Control and Prevention [CDC] unhealthy days) at 4- and 5-year follow-up assessments were the outcome measures. RESULTS Nearly half of the participants suffered from at least one episode of subthreshold depressive symptoms. After adjusting for potentially confounding factors, the risk of poor functioning/impaired health-related quality of life was nearly three times higher (relative risk = 2.86) for participants with four subthreshold depressive episodes compared with participants with no/minimal depression. Results suggest a dose-response relationship: the risk of poor functioning/impaired health-related quality of life increased with the number of recurrent subthreshold depressive episodes even after controlling for potentially confounding variables (significant linear trend, P < 0.001). CONCLUSIONS Recurrent subthreshold depressive symptoms might be an important risk factor for poor health outcomes in type 2 diabetes. Early identification, monitoring, and treatment of recurrent subthreshold depressive symptoms might improve functioning and quality of life in people with type 2 diabetes.

Entities:  

Mesh:

Year:  2013        PMID: 24198303     DOI: 10.2337/dc13-1832

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  18 in total

1.  Depression and risk of type 2 diabetes: the potential role of metabolic factors.

Authors:  N Schmitz; S S Deschênes; R J Burns; K J Smith; A Lesage; I Strychar; R Rabasa-Lhoret; C Freitas; E Graham; P Awadalla; J L Wang
Journal:  Mol Psychiatry       Date:  2016-02-23       Impact factor: 15.992

Review 2.  Japanese Clinical Practice Guideline for Diabetes 2019.

Authors:  Eiichi Araki; Atsushi Goto; Tatsuya Kondo; Mitsuhiko Noda; Hiroshi Noto; Hideki Origasa; Haruhiko Osawa; Akihiko Taguchi; Yukio Tanizawa; Kazuyuki Tobe; Narihito Yoshioka
Journal:  Diabetol Int       Date:  2020-07-24

Review 3.  Non-communicable disease syndemics: poverty, depression, and diabetes among low-income populations.

Authors:  Emily Mendenhall; Brandon A Kohrt; Shane A Norris; David Ndetei; Dorairaj Prabhakaran
Journal:  Lancet       Date:  2017-03-04       Impact factor: 79.321

Review 4.  Depression in type 2 diabetes mellitus: prevalence, impact, and treatment.

Authors:  Katherine Semenkovich; Miriam E Brown; Dragan M Svrakic; Patrick J Lustman
Journal:  Drugs       Date:  2015-04       Impact factor: 9.546

Review 5.  Subclinical inflammation and depressive symptoms in patients with type 1 and type 2 diabetes.

Authors:  Christian Herder; Norbert Hermanns
Journal:  Semin Immunopathol       Date:  2019-02-18       Impact factor: 9.623

Review 6.  Function of the GABAergic System in Diabetic Encephalopathy.

Authors:  Hongli Zhou; Zhili Rao; Zuo Zhang; Jiyin Zhou
Journal:  Cell Mol Neurobiol       Date:  2022-04-23       Impact factor: 5.046

7.  Diabetes, depressive symptoms, and functional disability in African Americans: the Jackson Heart Study.

Authors:  Rita Rastogi Kalyani; Nan Ji; Mercedes Carnethon; Alain G Bertoni; Elizabeth Selvin; Edward W Gregg; Mario Sims; Sherita Hill Golden
Journal:  J Diabetes Complications       Date:  2017-03-09       Impact factor: 2.852

8.  Application of the actor-partner interdependence model in parent-adolescent emotion regulation and depression.

Authors:  Jennifer C Wolff; Sarah A Thomas; Erik Hood; Alexandra H Bettis; Christie J Rizzo; Richard T Liu
Journal:  J Affect Disord       Date:  2020-09-02       Impact factor: 4.839

9.  Japanese Clinical Practice Guideline for Diabetes 2019.

Authors:  Eiichi Araki; Atsushi Goto; Tatsuya Kondo; Mitsuhiko Noda; Hiroshi Noto; Hideki Origasa; Haruhiko Osawa; Akihiko Taguchi; Yukio Tanizawa; Kazuyuki Tobe; Narihito Yoshioka
Journal:  J Diabetes Investig       Date:  2020-07       Impact factor: 4.232

10.  Associations Between Glycemic Control, Depressed Mood, Clinical Depression, and Diabetes Distress Before and After Insulin Initiation: An Exploratory, Post Hoc Analysis.

Authors:  Haya Ascher-Svanum; Anthony Zagar; Dingfeng Jiang; Dara Schuster; Henry Schmitt; Ellen B Dennehy; David M Kendall; Joel Raskin; Robert J Heine
Journal:  Diabetes Ther       Date:  2015-07-10       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.